TGF-βresponsive myeloid cells suppress type 2 immunity and emphysematous pathology after hookworm infection

American Journal of Pathology

Volumn 181, Issue 3, 2012, Pages 897-906

  Heitmann, Lisa ^a   Rani, Reena ^b   Dawson, Lucas ^b   Perkins, Charles ^b   Yang, Yanfen ^b   Downey, Jordan ^b   Hlscher, Christoph ^a   Herbert, De'Broski R ^b,c  

^a RESEARCH CENTER BORSTEL   (Germany)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BREATHING RATE; CONTROLLED STUDY; EMPHYSEMA; ENZYME ACTIVITY; HOOKWORM INFECTION; IMMUNITY; IMMUNOREGULATION; LUNG ALVEOLUS MACROPHAGE; LUNG COMPLIANCE; LUNG FIBROSIS; LUNG PARENCHYMA; MOUSE; NEUTROPHIL; NIPPOSTRONGYLUS BRASILIENSIS; NONHUMAN; PHAGOCYTE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TOTAL LUNG CAPACITY; UPREGULATION; WOUND HEALING;

ANIMALS; BONE MARROW CELLS; EMPHYSEMA; HOOKWORM INFECTIONS; IMMUNITY; LUNG; LYMPHOCYTE ACTIVATION; MACROPHAGES, ALVEOLAR; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; NIPPOSTRONGYLUS; PNEUMONIA; PROTEIN-SERINE-THREONINE KINASES; PULMONARY FIBROSIS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84865245705     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.05.032     Document Type: Article

References (61)

1. J. Massagu, S.W. Blain, R.S. Lo TGFbeta signaling in growth control, cancer, and heritable disorders Cell 103 2000 295 309
2. D.A. Thomas, J. Massagu TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance Cancer Cell 8 2005 369 380
3. A. Hall, J. Massagu Cell regulation Curr Opin Cell Biol 20 2008 117 118
4. M.M. Shull, I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, T. Doetschman Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease Nature 359 1992 693 699
5. M.A. Kriegel, M.O. Li, S. Sanjabi, Y.Y. Wan, R.A. Flavell Transforming growth factor-beta: recent advances on its role in immune tolerance Curr Rheumatol Rep 8 2006 138 144
6. M.O. Li, S. Sanjabi, R.A. Flavell Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms Immunity 25 2006 455 471
7. M.O. Li, Y.Y. Wan, S. Sanjabi, A.K. Robertson, R.A. Flavell Transforming growth factor-beta regulation of immune responses Annu Rev Immunol 24 2006 99 146
8. M. Shah, D. Revis, S. Herrick, R. Baillie, S. Thorgeirson, M. Ferguson, A. Roberts Role of elevated plasma transforming growth factor-beta1 levels in wound healing Am J Pathol 154 1999 1115 1124
9. A. Gratchev, J. Kzhyshkowska, S. Kannookadan, M. Ochsenreiter, A. Popova, X. Yu, S. Mamidi, E. Stonehouse-Usselmann, I. Muller-Molinet, L. Gooi, S. Goerdt Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II J Immunol 180 2008 6553 6565
10. M.W. Feinberg, M.K. Jain, F. Werner, N.E. Sibinga, P. Wiesel, H. Wang, J.N. Topper, M.A. Perrella, M.E. Lee Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages J Biol Chem 275 2000 25766 25773
11. F. Werner, M.K. Jain, M.W. Feinberg, N.E. Sibinga, A. Pellacani, P. Wiesel, M.T. Chin, J.N. Topper, M.A. Perrella, M.E. Lee Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3 J Biol Chem 275 2000 36653 36658
12. D.R. Herbert, T. Orekov, A. Roloson, M. Ilies, C. Perkins, W. O'Brien, S. Cederbaum, D.W. Christianson, N. Zimmermann, M.E. Rothenberg, F.D. Finkelman Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis J Immunol 184 2010 6438 6446
13. A. Zhao, J.F. Urban Jr, R.M. Anthony, R. Sun, J. Stiltz, N. van Rooijen, T.A. Wynn, W.C. Gause, T. Shea-Donohue Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages Gastroenterology 135 2008 217 225.e1
14. R.M. Anthony, J.F. Urban Jr, F. Alem, H.A. Hamed, C.T. Rozo, J.L. Boucher, N. Van Rooijen, W.C. Gause Memory TH2 cells induce alternatively activated macrophages to mediate protection against nematode parasites Nat Med 12 2006 955 960
15. J.R. Grainger, K.A. Smith, J.P. Hewitson, H.J. McSorley, Y. Harcus, K.J. Filbey, C.A. Finney, E.J. Greenwood, D.P. Knox, M.S. Wilson, Y. Belkaid, A.Y. Rudensky, R.M. Maizels Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway J Exp Med 207 2010 2331 2341
16. J.T. Pesce, T.R. Ramalingam, M.M. Mentink-Kane, M.S. Wilson, K.C. El Kasmi, A.M. Smith, R.W. Thompson, A.W. Cheever, P.J. Murray, T.A. Wynn Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis PLoS Pathog 5 2009 e1000371
17. J.T. Pesce, T.R. Ramalingam, M.S. Wilson, M.M. Mentink-Kane, R.W. Thompson, A.W. Cheever, J.F. Urban Jr, T.A. Wynn Retnla (relmalpha/fizz1) suppresses helminth-induced Th2-type immunity PLoS Pathog 5 2009 e1000393
18. A.J. Coyle, G. Kohler, S. Tsuyuki, F. Brombacher, M. Kopf Eosinophils are not required to induce airway hyperresponsiveness after nematode infection Eur J Immunol 28 1998 2640 2647
19. M. Wills-Karp, J. Luyimbazi, X. Xu, B. Schofield, T.Y. Neben, C.L. Karp, D.D. Donaldson Interleukin-13: central mediator of allergic asthma Science 282 1998 2258 2261
20. B.J. Marsland, M. Kurrer, R. Reissmann, N.L. Harris, M. Kopf Nippostrongylus brasiliensis infection leads to the development of emphysema associated with the induction of alternatively activated macrophages Eur J Immunol 38 2008 479 488
21. A. Chytil, M.A. Magnuson, C.V. Wright, H.L. Moses Conditional inactivation of the TGF-beta type II receptor using Cre: Lox Genesis 32 2002 73 75
22. D.R. Herbert, J.Q. Yang, S.P. Hogan, K. Groschwitz, M. Khodoun, A. Munitz, T. Orekov, C. Perkins, Q. Wang, F. Brombacher, J.F. Urban Jr, M.E. Rothenberg, F.D. Finkelman Intestinal epithelial cell secretion of RELM-b protects against gastrointestinal worm infection J Exp Med 206 2009 2947 2957
23. D.R. Herbert, C. Hlscher, M. Mohrs, B. Arendse, A. Schwegmann, M. Radwanska, M. Leeto, R. Kirsch, P. Hall, H. Mossmann, B. Claussen, I. Frster, F. Brombacher Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology [Erratum appeared in Immunity 2004, 21:455] Immunity 20 2004 623 635
24. F.D. Finkelman, S.C. Morris Development of an assay to measure in vivo cytokine production in the mouse Int Immunol 11 1999 1811 1818
25. E. Salazar, J.H. Knowles An analysis of pressure-volume characteristics of the lungs J Appl Physiol 19 1964 97 104
26. T. Frugier, K. Koishi, K.I. Matthaei, I.S. McLennan Transgenic mice carrying a tetracycline-inducible, truncated transforming growth factor beta receptor (TbetaRII) Genesis 42 2005 1 5
27. Y. Laouar, F.S. Sutterwala, L. Gorelik, R.A. Flavell Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma Nat Immunol 6 2005 600 607
28. M. Plantinga, H. Hammad, B.N. Lambrecht Origin and functional specializations of DC subsets in the lung Eur J Immunol 40 2010 2112 2118
29. H. Hammad, M. Plantinga, K. Deswarte, P. Pouliot, M.A. Willart, M. Kool, F. Muskens, B.N. Lambrecht Inflammatory dendritic cellsnot basophilsare necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen J Exp Med 207 2010 2097 2111
30. K.P. Walsh, M.T. Brady, C.M. Finlay, L. Boon, K.H. Mills Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses J Immunol 183 2009 1577 1586
31. + T cell hyporesponsiveness at sites peripheral to filarial infection J Immunol 176 2006 6918 6927
32. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, A. Sica Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 2002 549 555
33. R.M. Maizels, A. Balic, N. Gomez-Escobar, M. Nair, M.D. Taylor, J.E. Allen Helminth parasitesmasters of regulation Immunol Rev 201 2004 89 116
34. J.L. Reyes, L.I. Terrazas The divergent roles of alternatively activated macrophages in helminthic infections Parasite Immunol 29 2007 609 619
35. F. Chen, Z. Liu, W. Wu, C. Rozo, S. Bowdridge, A. Millman, N. Van Rooijen, J.F. Urban Jr, T.A. Wynn, W.C. Gause An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection Nat Med 18 2012 260 266
36. J.J. Reece, M.C. Siracusa, T.L. Southard, C.F. Brayton, J.F. Urban Jr, A.L. Scott Hookworm-induced persistent changes to the immunological environment of the lung Infect Immun 76 2008 3511 3524
37. M.C. Siracusa, J.J. Reece, J.F. Urban Jr, A.L. Scott Dynamics of lung macrophage activation in response to helminth infection J Leukoc Biol 84 2008 1422 1433
38. S. Gordon, F.O. Martinez Alternative activation of macrophages: mechanism and functions Immunity 32 2010 593 604
39. L. Barron, T.A. Wynn Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages Am J Physiol Gastrointest Liver Physiol 300 2011 G723 G728
40. T.A. Wynn, L. Barron Macrophages: master regulators of inflammation and fibrosis Semin Liver Dis 30 2010 245 257
41. T.A. Wynn Integrating mechanisms of pulmonary fibrosis J Exp Med 208 2011 1339 1350
42. M.D. Taylor, L. LeGoff, A. Harris, E. Malone, J.E. Allen, R.M. Maizels Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo J Immunol 174 2005 4924 4933
43. M.S. Wilson, M.D. Taylor, A. Balic, C.A. Finney, J.R. Lamb, R.M. Maizels Suppression of allergic airway inflammation by helminth-induced regulatory T cells J Exp Med 202 2005 1199 1212
44. R. Rani, A.G. Smulian, D.R. Greaves, S.P. Hogan, D.R. Herbert TGF-beta limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function Eur J Immunol 41 2011 2000 2009
45. N.E. Humphreys, D. Xu, M.R. Hepworth, F.Y. Liew, R.K. Grencis IL-33, a potent inducer of adaptive immunity to intestinal nematodes J Immunol 180 2008 2443 2449
46. J. Schmitz, A. Owyang, E. Oldham, Y. Song, E. Murphy, T.K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, D.M. Gorman, J.F. Bazan, R.A. Kastelein IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
47. M. Kurowska-Stolarska, B. Stolarski, P. Kewin, G. Murphy, C.J. Corrigan, S. Ying, N. Pitman, A. Mirchandani, B. Rana, N. van Rooijen, M. Shepherd, C. McSharry, I.B. McInnes, D. Xu, F.Y. Liew IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation J Immunol 183 2009 6469 6477
48. Z.G. Fridlender, J. Sun, S. Kim, V. Kapoor, G. Cheng, L. Ling, G.S. Worthen, S.M. Albelda Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN Cancer Cell 16 2009 183 194
49. M. Lisbonne, A. L'Helgoualc'h, G. Nauwelaers, B. Turlin, C. Lucas, A. Herbelin, C. Piquet-Pellorce, M. Samson Invariant natural killer T-cell-deficient mice display increased CCl -induced hepatitis associated with CXCL1 over-expression and neutrophil infiltration Eur J Immunol 41 2011 1720 1732
50. S.K. Ahuja, P.M. Murphy The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor J Biol Chem 271 1996 20545 20550
51. C. Ma, R.W. Tarnuzzer, N. Chegini Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1 Wound Repair Regen 7 1999 477 485
52. R.E. Morty, M. Knigshoff, O. Eickelberg Transforming growth factor-beta signaling across ages: from distorted lung development to chronic obstructive pulmonary disease Proc Am Thorac Soc 6 2009 607 613
53. S. Keely, N.J. Talley, P.M. Hansbro Pulmonary-intestinal cross-talk in mucosal inflammatory disease Mucosal Immunol 5 2012 7 18
54. A. Adler, G. Cieslewicz, C.G. Irvin Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice J Appl Physiol 97 2004 286 292
55. M. Knigshoff, F. Uhl, R. Gosens From molecule to man: integrating molecular biology with whole organ physiology in studying respiratory disease Pulm Pharmacol Ther 24 2011 466 470
56. D.J. Lederer, S.M. Arcasoy Update in surgical therapy for chronic obstructive pulmonary disease Clin Chest Med 28 2007 639 653 vii
57. B.F. Meyers, G.A. Patterson Chronic obstructive pulmonary disease 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease Thorax 58 2003 634 638
58. C.M. Greene, T. Hassan, K. Molloy, N.G. McElvaney The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and alpha-1 anti-trypsin deficiency Expert Rev Respir Med 5 2011 395 411
59. M. Knigshoff, N. Kneidinger, O. Eickelberg TGF-beta signaling in COPD: deciphering genetic and cellular susceptibilities for future therapeutic regimen Swiss Med Wkly 139 2009 554 563
60. S. Baraldo, E. Bazzan, G. Turato, F. Calabrese, B. Begh, A. Papi, P. Maestrelli, L.M. Fabbri, R. Zuin, M. Saetta Decreased expression of TGF-beta type II receptor in bronchial glands of smokers with COPD Thorax 60 2005 998 1002
61. A.R. Pons, J. Sauleda, A. Noguera, J. Pons, B. Barcel, A. Fuster, A.G. Agusti Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease Eur Respir J 26 2005 60 66